BIVISION
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Mar 2025)
What this means for you
This application is over — abandoned 03 Mar 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98141705
- Mark type
- Design + words
- Filed
- 20 Aug 2023
- Published for opposition
- 28 May 2024
- Abandoned
- 03 Mar 2025
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic radiopharmaceutical agent for use in PET imaging; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medicinal use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in urology; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents
Owner
- Bivision Pharmaceuticals(Shanghai),Inc., Shanghai, CN
- Bivision Pharmaceuticals(Shanghai),Inc., Shanghai, CN
- Bivision Pharmaceuticals(Nanjing),Inc., Nanjing, CN
- Bivision Pharmaceuticals(Nanjing),Inc., Nanjing, CN
Prosecution history
- 02 Jun 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 02 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 03 Mar 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Mar 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Mar 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION
- 08 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Apr 2024 — EXAMINER'S AMENDMENT ENTERED
- 19 Apr 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Apr 2024 — EXAMINERS AMENDMENT E-MAILED
- 19 Apr 2024 — EXAMINERS AMENDMENT -WRITTEN